These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 21203772)
1. Management of pulmonary hypertension in Down syndrome. Hawkins A; Langton-Hewer S; Henderson J; Tulloh RM Eur J Pediatr; 2011 Jul; 170(7):915-21. PubMed ID: 21203772 [TBL] [Abstract][Full Text] [Related]
2. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response. Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310 [TBL] [Abstract][Full Text] [Related]
3. Pulmonary vascular complications of chronic airway obstruction in children. Jacobs IN; Teague WG; Bland JW Arch Otolaryngol Head Neck Surg; 1997 Jul; 123(7):700-4. PubMed ID: 9236588 [TBL] [Abstract][Full Text] [Related]
4. Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Apitz C; Hansmann G; Schranz D Heart; 2016 May; 102 Suppl 2():ii23-9. PubMed ID: 27053694 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Adverse Events in Children with Pulmonary Hypertension Undergoing Cardiac Catheterization. Vaiyani D; Kelleman M; Downey LA; Kanaan U; Petit CJ; Bauser-Heaton H Pediatr Cardiol; 2021 Apr; 42(4):736-742. PubMed ID: 33512547 [TBL] [Abstract][Full Text] [Related]
7. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease. Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131 [TBL] [Abstract][Full Text] [Related]
8. Dose response to inhaled nitric oxide in pediatric patients with pulmonary hypertension and acute respiratory distress syndrome. Nakagawa TA; Morris A; Gomez RJ; Johnston SJ; Sharkey PT; Zaritsky AL J Pediatr; 1997 Jul; 131(1 Pt 1):63-9. PubMed ID: 9255193 [TBL] [Abstract][Full Text] [Related]
9. Reversal of pulmonary hypertension in children after adenoidectomy or adenotonsillectomy. Martha VF; Moreira Jda S; Martha AS; Velho FJ; Eick RG; Goncalves SC Int J Pediatr Otorhinolaryngol; 2013 Feb; 77(2):237-40. PubMed ID: 23245625 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of pulmonary arterial hypertension associated with Down syndrome. Saji T Pediatr Int; 2014 Jun; 56(3):297-303. PubMed ID: 24689825 [TBL] [Abstract][Full Text] [Related]
11. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Carmosino MJ; Friesen RH; Doran A; Ivy DD Anesth Analg; 2007 Mar; 104(3):521-7. PubMed ID: 17312201 [TBL] [Abstract][Full Text] [Related]
12. Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease. Morris K; Beghetti M; Petros A; Adatia I; Bohn D Crit Care Med; 2000 Aug; 28(8):2974-8. PubMed ID: 10966281 [TBL] [Abstract][Full Text] [Related]
13. Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. Atz AM; Adatia I; Lock JE; Wessel DL J Am Coll Cardiol; 1999 Mar; 33(3):813-9. PubMed ID: 10080486 [TBL] [Abstract][Full Text] [Related]
14. Simplified pulmonary vasodilatory testing in the cardiac catheterization laboratory with nasal cannula nitric oxide. Scheurer M; Bandisode V; Atz AM Pediatr Cardiol; 2006; 27(1):84-86. PubMed ID: 16261276 [TBL] [Abstract][Full Text] [Related]
15. Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension). Beghetti M; Schulze-Neick I; Berger RM; Ivy DD; Bonnet D; Weintraub RG; Saji T; Yung D; Mallory GB; Geiger R; Berger JT; Barst RJ; Humpl T; Int J Cardiol; 2016 Jan; 203():325-30. PubMed ID: 26583838 [TBL] [Abstract][Full Text] [Related]
16. Management of pulmonary hypertension and Down syndrome. King P; Tulloh R Int J Clin Pract Suppl; 2011 Dec; (174):8-13. PubMed ID: 22171818 [TBL] [Abstract][Full Text] [Related]
17. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. Ivy DD; Doran AK; Smith KJ; Mallory GB; Beghetti M; Barst RJ; Brady D; Law Y; Parker D; Claussen L; Abman SH J Am Coll Cardiol; 2008 Jan; 51(2):161-9. PubMed ID: 18191742 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension. Beghetti M; Rudzinski A; Zhang M BMC Cardiovasc Disord; 2017 Jul; 17(1):177. PubMed ID: 28676038 [TBL] [Abstract][Full Text] [Related]
19. Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients. Beghetti M; Habre W; Friedli B; Berner M Br Heart J; 1995 Jan; 73(1):65-8. PubMed ID: 7888265 [TBL] [Abstract][Full Text] [Related]
20. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects. Li Q; Dimopoulos K; Zhang C; Zhu Y; Liu Q; Gu H Pediatr Cardiol; 2018 Apr; 39(4):757-762. PubMed ID: 29426959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]